Logo

GenDx's Amplification Primers for HLA Genes Receives CE Marking

Jun 24, 2014 | staff reporter

NEW YORK (GenomeWeb) – GenDx today said that its NGSgo-AmpX for amplifying complete HLA genes for downstream sequencing has received CE marking.

The amplification primers can be used for Sanger sequencing and certain next-generation sequencing approaches and is the first CE-marked product for HLA typing for NGS, GenDx said. The product is platform-agnostic and suitable for the Illumina MiSeq, Ion Torrent PGM, and PacBio RS systems, among others.

Last week, the Dutch molecular diagnostics firm announced that it and PacBio would co-market products aimed at full-length HLA gene sequencing.

Filed under

Clinical Sequencing
Sequencing
PCR
Regulatory News & FDA Approvals
amplification
CE mark
Next-Generation Sequencing
Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.